Literature DB >> 18987489

Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.

Megumi Shimoyama1, Hazel H Szeto, Peter W Schiller, Yugo Tagaito, Hideyuki Tokairin, Chong moon Eun, Naohito Shimoyama.   

Abstract

AIMS: H-Dmt-D-Arg-Phe-Lys-NH(2) ([Dmt(1)]DALDA), a highly selective micro-opioid peptide, is potently analgesic after systemic and intrathecal administration but is less potent given intracerebroventricularly. This study was performed to further characterize the analgesic effects of [Dmt(1)]DALDA.
METHODS: We compared the effects of [Dmt(1)]DALDA and morphine after systemic administration in two different acute pain tests, the tail flick test and the paw withdrawal test, and examined how antagonizing the spinal opioid actions would affect their analgesic effects.
RESULTS: [Dmt(1)]DALDA was markedly more potent in the tail flick test than in the hot plate test, while the potencies of morphine were similar in the two tests. Intrathecal naloxone completely blocked the effect of systemic [Dmt(1)]DALDA in the tail flick test, while it only partially blocked the effect of morphine. At higher doses that produced analgesia in the hot plate test, the effect of [Dmt(1)]DALDA in this test was only partially blocked by naloxone.
CONCLUSION: Systemic [Dmt(1)]DALDA has a unique analgesic property clearly different from that of morphine and it has a propensity to produce spinal analgesia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987489      PMCID: PMC2834256          DOI: 10.1159/000167878

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  11 in total

Review 1.  Animal models of nociception.

Authors:  D Le Bars; M Gozariu; S W Cadden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 25.468

2.  Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia.

Authors:  I Sora; N Takahashi; M Funada; H Ujike; R S Revay; D M Donovan; L L Miner; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Sites of antinociceptive action of systemically injected morphine: involvement of supraspinal loci as revealed by intracerebroventricular injection of naloxone.

Authors:  J C Yeung; T A Rudy
Journal:  J Pharmacol Exp Ther       Date:  1980-12       Impact factor: 4.030

4.  Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.

Authors:  M Shimoyama; N Shimoyama; G M Zhao; P W Schiller; H H Szeto
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

5.  Alpha 2-adrenoceptor modulation of nociception in rat spinal cord: location, effects and interactions with morphine.

Authors:  A F Sullivan; M R Dashwood; A H Dickenson
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

6.  Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.

Authors:  Claire L Neilan; Adam J Janvey; Elizabeth Bolan; Irena Berezowska; Thi M-D Nguyen; Peter W Schiller; Gavril W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  2003-03-27       Impact factor: 4.030

7.  Synthesis and in vitro opioid activity profiles of DALDA analogues.

Authors:  P W Schiller; T M Nguyen; I Berezowska; S Dupuis; G Weltrowska; N N Chung; C Lemieux
Journal:  Eur J Med Chem       Date:  2000-10       Impact factor: 6.514

Review 8.  Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.

Authors:  T L Yaksh
Journal:  Pharmacol Biochem Behav       Date:  1985-05       Impact factor: 3.533

9.  Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury.

Authors:  Kesheng Zhao; Guo-Min Zhao; Dunli Wu; Yi Soong; Alex V Birk; Peter W Schiller; Hazel H Szeto
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

10.  Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors.

Authors:  Guo-Min Zhao; Dunli Wu; Yi Soong; Megumi Shimoyama; Irena Berezowska; Peter W Schiller; Hazel H Szeto
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

View more
  1 in total

1.  Superior analgesic effect of H-Dmt-D-Arg-Phe-Lys-NH2 ([Dmt1]DALDA), a multifunctional opioid peptide, compared to morphine in a rat model of neuropathic pain.

Authors:  Megumi Shimoyama; Peter W Schiller; Naohito Shimoyama; Satoshi Toyama; Hazel H Szeto
Journal:  Chem Biol Drug Des       Date:  2012-09-03       Impact factor: 2.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.